Publications
Explore our latest scientific posters, presentations, and peer-reviewed publications that highlight the potential of our therapies to advance treatment for immune-mediated diseases.
Budoprutug
Poster: A Phase 1b Single Arm Open-Label Study of Budoprutug, an Anti-CD19 Monoclonal Antibody with Enhanced ADCC, in Primary Membranous Nephropathy (pMN) »
Presented at the American Society of Nephrology (ASN) Kidney Week, October 23-24, 2024
Poster: A Tunable Scalable Platform for Precise Fucosylation Control to Enhance Efficacy of Therapeutic Antibodies: Application to Clinical Manufacturing of Budoprutug »
Presented at PEGS Boston – The Essential Protein Engineering & Cell Therapy Summit, May 12-16, 2025